Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

54results about How to "Safely ingested" patented technology

Compositions and Methods for Oral Administration of Cannabinoids and Terpenoids

ActiveUS20190060225A1Precise and reliable dosageAct quicklyOrganic active ingredientsPowder deliveryDelivery vehicleCannabis Preparation
The present invention relates to oral administration of water soluble cannabinoid and terpenoid concentrates on a flavored fibrous carrier. The compositions described herein provide an alternative to smoked cannabis that also avoid the slow action and unpredictable dosing of edible cannabis preparations. Water soluble concentrates of cannabinoids and terpenoids may be produced by derivatization reactions which are known in the art. Such water soluble concentrates enjoy significantly increased absorption by mucosal membranes of the mouth and may therefore be experienced by the consumer more quickly. Water soluble cannabinoid and terpenoid concentrates may be used in combination with each other and in combination with non-derivatized molecules which provides the user with fast and slow acting components in a single delivery vehicle.
Owner:TRINIDAD CONSULTING LLC

Virucidal activities of cetylpyridinium chloride

This disclosure relates to inventive methods for inactivating viral pathogens in which the steps of the methods include: (a) providing a virucidal composition comprising a liquid media containing less than 1% weight per volume cetylpyridinium chloride; and (b) contacting the virucidal composition with a surface targeted for disinfection. This disclosure further relates to inventive virucidal compositions, in which the compositions include: (a) a liquid media; (b) cetylpyridinium chloride in solution in the liquid media at a concentration of less than 1% weight per volume; (c) an extender; and (d) an enhancer.
Owner:VIRATOX

Adiponectin secretion enhancer

The present disclosure provides for the administration of β-NMN, which increases the secretion of adiponectin. The present disclosure also provides an adiponectin secretion enhancer comprising β-nicotinamide mononucleotide, a pharmaceutically acceptable salt thereof or a solvate thereof, and a dietary supplement containing the aforementioned secretion enhancer, which can he ingested in order to increase the secretion of adiponectin. Also disclosed are methods of treating insulin resistance-related diseases such as of metabolic syndrome, diabetes, hyperlipidemia, fatty liver disease, hypertension, obesity, and arteriosclerosis.
Owner:ORIENTAL YEAST +1

Aloe Vera Extract, Method of Producing Aloe Vera Extract, and Hyperglycemia Improving Agent

InactiveUS20090004307A1Significant hyperglycemia improving effectReduce contentOrganic active ingredientsBiocideAcute hyperglycaemiaLifestyle disease
The present invention provides: an Aloe vera extract that can be safely ingested, can be used as a material of food for preventing lifestyle diseases, contains an extremely low level of an anthraquinone (anthraquinone-based compound), and can be added to foods; and a method of producing the Aloe vera extract. A supercritical fluid extraction method can produce an Aloe vera extract containing a mixture that consists of a cyclolanostane compound and a lophenol compound in an amount of 1.0% by mass or more and having the following properties (1) and / or (2):(1) the mass mixing ratio of the cyclolanostane compound and lophenol compound is as follows:cyclolanostane compound: lophenol compound=6.3:2.7 to 5.1:4.9; and / or(2) the content of an anthraquinone-based compound is 0.001% by mass or less.
Owner:MORINAGA MILK IND CO LTD

Fragmentor for bird ingestible gas turbine engine

In an aircraft turbofan or turbojet engine including a fan blade assembly mounted thereon rotating about the central axis of the engine, there are provided aerodynamically profiled rotating cutting rings arranged concentrically to the engine axis upstream of the fan blade assembly on which a bird traveling toward the engine will fragment to extravasations and evisceration to produce bird debris of a sufficiently low density to be safely ingested by the engine.
Owner:CUPOLO FRANCIS J

Composition for preventing or improving peripheral neuropathy

Compositions which contain an amino acid containing serine and a lipid containing a n-3 fatty acid are useful for the prophylaxis or improvement of peripheral neuropathy.
Owner:AJINOMOTO CO INC

Highly bioavailable oral administration composition of cryptoxanthin

A composition having improved bioavailability, of cryptoxanthin derived from a natural product, particularly that derived from Citrus unshiu Marc known to be rich in cryptoxanthin, and a method for economically and conveniently producing the same are provided. As a cryptoxanthin highly bioavailable oral administration composition, which is a composition comprising natural product-derived cryptoxanthin, wherein the amount of dietary fibers contained in said composition is 400 times by weight or less based on cryptoxanthin, this composition is a composition wherein the bioavailability of cryptoxanthin is improved 2 times or more in comparison with the case of directly ingesting a natural product containing said cryptoxanthin.
Owner:UNITIKA LTD

Agent for improving insulin resistance

To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an organic solvent extract, a hot water extract or a squeezed liquid of a plant of the family Liliaceae or a fraction thereof which contains the compound as an active ingredient.
Owner:MORINAGA MILK IND CO LTD

Agent for improving insulin resistance

To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient.
Owner:MORINAGA MILK IND CO LTD

Agent for inhibiting visceral fat accumulation

To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity, considered to be a main factor of metabolic syndrome, the present invention provides an agent or a food or drink which contains a compound having a lophenol skeleton, or an organic solvent extract or a hot water extract of a Liliaceae plant, or a fraction thereof containing the compound is used as an active ingredient.
Owner:MORINAGA MILK IND CO LTD

Agent for improving insulin resistance

To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, or an organic solvent extract, a hot water extract or a squeezed liquid of a plant of the family Liliaceae or a fraction thereof which contains the compound as an active ingredient.
Owner:MORINAGA MILK IND CO LTD

Fluid Supplement with Prenatal Vitamins

InactiveUS20130115201A1Combat symptom of nausea and vomitingImprove palatabilityBiocideSugar food ingredientsFlavorDietary supplement
A fluid supplement is provided that is specifically tailored to meet the health and nutritional needs of a pregnant woman and her developing fetus. The fluid supplement also combats the symptoms of nausea and vomiting that are commonly associated with pregnancy. The fluid supplement contains vitamins, minerals, dietary supplements, and flavor-enhancing ingredients in amounts that safely provide health and nutritional benefits to both the woman and her developing fetus. By using the fluid supplement, a pregnant woman is able to obtain the health and nutritional benefits in a single dose of a palatable fluid supplement instead of having to swallow multiple pills per day.
Owner:GLEESON MICHAEL PATRICK

Drug for improving hyperglycemia

A compound having a hyperglycemia improving effect and a hemoglobin A1c lowering action such as 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol and 4-methylstigmast-7-en-3-ol is used as an active ingredient of a drug or food or drink for improving hyperglycemia.
Owner:MORINAGA MILK IND CO LTD

Tamper-evident containers

Various tamper-evident and / or tamper-resistant containers are disclosed. In some embodiments, the container comprises a base and a lid. The base can receive a food product. The lid can be engaged with the base to form a closed chamber in the container. In some embodiments, the lid is received in a peripheral channel in the base and / or recessed below an upper lip of the base to inhibit grasping of a peripheral edge of the lid. The lid can have a tab and a recess. The tab can be positioned in the recess. An indicator can overlay the tab in the recess. To open the container, the tab is drawn upward which pulls the lid out of engagement with the base. Removing the tab from the recess tears or otherwise mars the appearance of the indicator.
Owner:PINNPACK PACKAGING LLC

Drug And Food Or Drink For Improving Pancreatic Functions

3-O-β-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a fraction thereof containing the compound, is used as an active ingredient of a drug for improving pancreatic functions.
Owner:MORINAGA MILK IND CO LTD

Drug and food or drink for improving pancreatic functions

ActiveUS7531520B2Function increaseEasy to getBiocideOrganic active ingredientsPANCREATIC FUNCTIONSFamily liliaceae
3-O-β-D-Glucopyranosyl-4-methyl-ergost-7-en-3-ol or a composition containing 0.001 to 10% by dry mass of the aforementioned compound, which is an extract of a plant of the family Liliaceae or a fraction thereof containing the compound, is used as an active ingredient of a drug for improving pancreatic functions.
Owner:MORINAGA MILK IND CO LTD

Adiponectin secretion enhancer

The present disclosure provides for the administration of β-NMN, which increases the secretion of adiponectin. The present disclosure also provides an adiponectin secretion enhancer comprising β-nicotinamide mononucleotide, a pharmaceutically acceptable salt thereof or a solvate thereof, and a dietary supplement containing the aforementioned secretion enhancer, which can be ingested in order to increase the secretion of adiponectin. Also disclosed are methods of treating insulin resistance-related diseases such as of metabolic syndrome, diabetes, hyperlipidemia, fatty liver disease, hypertension, obesity, and arteriosclerosis.
Owner:ORIENTAL YEAST +1

Compositions and methods for oral administration of cannabinoids and terpenoids

The present invention relates to oral administration of water soluble cannabinoid and terpenoid concentrates on a flavored fibrous carrier. The compositions described herein provide an alternative to smoked cannabis that also avoid the slow action and unpredictable dosing of edible cannabis preparations. Water soluble concentrates of cannabinoids and terpenoids may be produced by derivatization reactions which are known in the art. Such water soluble concentrates enjoy significantly increased absorption by mucosal membranes of the mouth and may therefore be experienced by the consumer more quickly. Water soluble cannabinoid and terpenoid concentrates may be used in combination with each other and in combination with non-derivatized molecules which provides the user with fast and slow acting components in a single delivery vehicle.
Owner:TRINIDAD CONSULTING LLC

Agent for inhibiting visceral fat accumulation

To reduce amounts of fat accumulated in abdominal cavity and to prevent or ameliorate visceral fat type obesity considered to be a main factor of metabolic syndrome, there is provided an agent or a food or drink, including as an active ingredient 3-O-β-D-glucopyranosyl-4-methylergost-7-en-3-ol, an organic solvent extract, a hot water extract, a squeezed liquid of a Liliaceae plant or a fraction thereof which contains the compound.
Owner:MORINAGA MILK IND CO LTD

Skin pigmentation inhibitor

An object of the present invention is to provide a material which can be safely ingested and which inhibits skin pigmentation. Therefore, the invention is a skin pigmentation inhibitor, containing a β-nicotinamide mononucleotide or a pharmaceutically acceptable salt thereof; and a solvate thereof as an active ingredient; a health supplement which contains the skin pigmentation inhibitor and is ingested to inhibit skin pigmentation; and a method for inhibiting skin pigmentation, including ingesting the skin pigmentation inhibitor.
Owner:ORIENTAL YEAST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products